Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-28,658
Closed -$222K 552
2024
Q2
$222K Sell
28,658
-651,109
-96% -$5.81M ﹤0.01% 555
2024
Q1
$7.29M Sell
679,767
-22,328
-3% -$247K 0.04% 345
2023
Q4
$7.84M Sell
702,095
-10,803
-2% -$99.3K 0.04% 311
2023
Q3
$11M Buy
712,898
+57,092
+9% +$958K 0.07% 244
2023
Q2
$12.4M Buy
+655,806
New +$11.5M 0.07% 235

Other funds holding ETNB

Eagle Asset Management's ETNB Position: Q3 2024 in Review

Eagle Asset Management sold out of 89bio (ETNB) in Q3 2024, closing a stake of 28,658 shares — an estimated $222K sold.

Eagle Asset Management first reported a position in ETNB in Q2 2023 and held it in 5 quarters. The position peaked at $12.4M in Q2 2023. 144 funds tracked by Wall St. Rank hold ETNB as of Q3 2024.

  • Eagle Asset Management reported no remaining 89bio position as of Q3 2024 after selling out during the quarter.
  • Eagle Asset Management sold 28,658 89bio shares in Q3 2024, an estimated $222K.
  • Eagle Asset Management first reported a position in 89bio in Q2 2023 and held it in 5 quarters.
  • Eagle Asset Management's 89bio position peaked at $12.4M in Q2 2023.
  • 144 funds tracked by Wall St. Rank held 89bio as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.